2019年12月以來(lái)，武漢首先發(fā)現(xiàn)新型冠狀病毒肺炎，其他城市隨后出現(xiàn)此類病例。由新型冠狀病毒導(dǎo)致的疾病由世界衛(wèi)生組織正式命名為COVID-19（coronavirus disease 2019）。國(guó)家衛(wèi)健委以及其他省市先后對(duì)COVID-19進(jìn)行辨證分型，并提供對(duì)應(yīng)的中醫(yī)藥治療方案。中醫(yī)認(rèn)為該疫病屬“濕毒之邪”，治療的最佳原則為早發(fā)現(xiàn)早治療，中醫(yī)和西醫(yī)各有優(yōu)勢(shì)，可以優(yōu)勢(shì)互補(bǔ)，不能互相取代。因此全面收集中醫(yī)藥治療COVID-19的中醫(yī)藥用藥方案，進(jìn)行系統(tǒng)分析，尤其是對(duì)中醫(yī)藥治療COVID-19的藥理學(xué)基礎(chǔ)進(jìn)行分析，為中藥處方治療COVID-19的合理性提供參考以及為各省市更新診療方案提供依據(jù)。

Since December 2019, a novel coronavirus-infected pneumonia was first detected in Wuhan, such cases had been subsequently discovered in other cities. The disease caused by the novel coronavirus was officially named COVID-19 (coronavirus disease 2019) by the world health organization. National Health Commission of China and other provinces and cities have successively performed syndrome differentiation of COVID-19 and provided corresponding Chinese medicine treatment programs. In this epidemic, the disease is a "dampness toxin". The best principle for treatment is early detection and early treatment. Both Chinese and Western medicine have their own advantages. The advantages could be complementary and could not be replaced each other. Therefore, we collected the Chinese medicine treatment programs for the treatment of COVID-19 comprehensively, conducted a systematic analysis, and especially analyzed the pharmacological basis of traditional Chinese medicine for the treatment of COVID-19, which provided a basis for the rationality of Chinese medicine prescription for the treatment of COVID-19, and provided a reference of updating the diagnosis and treatment plan for provinces and cities.

R183.3;R285.6

甘肅省高校重大疾病分子醫(yī)學(xué)與中醫(yī)藥防治研究重點(diǎn)實(shí)驗(yàn)室NCP防治科研專項(xiàng)開(kāi)放基金（FZYX20-2，F(xiàn)ZYX20-12）；甘肅省新型冠狀病毒肺炎應(yīng)急科研專項(xiàng)